Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2014 - 2021)

Akebia Therapeutics (AKBA) has reported Change in Acquisitions & Divestments for 8 consecutive years, with $20.0 million the latest figure, recorded in Q2 2021.

• In Q2 2021, Change in Acquisitions & Divestments changed N/A year-over-year to $20.0 million; the TTM figure through Mar 2022 stood at $20.0 million (down 75.0% YoY), while the FY2021 annual figure was $40.0 million, down 33.6% from the prior year.
• Change in Acquisitions & Divestments held at $20.0 million in Q2 2021 per AKBA's latest filing, from $20.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $230.3 million in Q4 2018 and bottomed at -$65.9 million in Q4 2019.
• Historically, Change in Acquisitions & Divestments has averaged $34.9 million across 5 years, with a median of $27.1 million in 2017.
• Annual changes were most pronounced in 2019 — Change in Acquisitions & Divestments sank 128.61% — and 2021, when it jumped 8063.27%.
• Akebia Therapeutics' Change in Acquisitions & Divestments stood at $52.1 million in 2017, then soared by 341.72% to $230.3 million in 2018, then sank by 128.61% to -$65.9 million in 2019, then jumped by 191.06% to $60.0 million in 2020, then slumped by 66.67% to $20.0 million in 2021.
• Business Quant data shows AKBA's Change in Acquisitions & Divestments at $20.0 million in Q2 2021, $20.0 million in Q1 2021, and $60.0 million in Q4 2020.